Activation of the Wnt/beta-catenin signaling pathway decreases PPAR gamma activity in colon cancer cells (Jansson et al., 2005) and a loss-of-function mutations in PPAR gamma is associated with human colon cancer (Sarraf et al., 1999). The gene discussed is PPARG; the disease is colonic neoplasm.